These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 10679537
21. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM. Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734 [Abstract] [Full Text] [Related]
22. Use of ipratropium bromide in obstructive lung disease. Mann KV, Leon AL, Tietze KJ. Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109 [Abstract] [Full Text] [Related]
24. Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease. Yao W, Wang G, Zhu H, Sun Y, Zhao M. Chin Med J (Engl); 2001 Jan; 114(1):80-3. PubMed ID: 11779443 [Abstract] [Full Text] [Related]
26. A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia. Bar-Aluma BE, Efrati O, Kaufmann H, Palma JA, Norcliffe-Kaufmann L. Lung; 2018 Feb; 196(1):93-101. PubMed ID: 29234869 [Abstract] [Full Text] [Related]
27. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan. Hsu JY, Perng RP, Lu JY, Wu CP, Huang MS, Luh KT, Yang PC. J Formos Med Assoc; 2006 Sep; 105(9):708-14. PubMed ID: 16959618 [Abstract] [Full Text] [Related]
29. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Sin DD, Tu JV. Am J Respir Crit Care Med; 2001 Aug 15; 164(4):580-4. PubMed ID: 11520719 [Abstract] [Full Text] [Related]
30. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?]. Musil J, Hirsch V, Vondra V, Reisová M. Vnitr Lek; 1998 Jul 15; 44(7):415-7. PubMed ID: 9748878 [Abstract] [Full Text] [Related]
32. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. Tsukino M, Nishimura K, Ikeda A, Hajiro T, Koyama H, Izumi T. Thorax; 1998 Apr 15; 53(4):269-73. PubMed ID: 9741369 [Abstract] [Full Text] [Related]
33. Differences in mortality between patients attending the emergency room services for asthma and chronic obstructive pulmonary disease. Garcia-Aymerich J, Sunyer J, Domingo-Salvany A, Mcfarlane D, Montellà N, Pérez G, Antó JM. Respir Med; 1999 Nov 15; 93(11):822-6. PubMed ID: 10603632 [Abstract] [Full Text] [Related]
34. Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease. Gordon J, Panos RJ. Expert Opin Drug Metab Toxicol; 2010 Mar 15; 6(3):381-92. PubMed ID: 20163324 [Abstract] [Full Text] [Related]
35. [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma]. Dor A, Krasnowska M, Małolepszy J. Pneumonol Alergol Pol; 1994 Mar 15; 62(1-2):75-9. PubMed ID: 8075617 [Abstract] [Full Text] [Related]
39. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma. Maesen FP, Greefhorst LP, Smeets JJ, Wald FD, Cornelissen PJ. Respiration; 1997 Feb 15; 64(4):273-80. PubMed ID: 9257362 [Abstract] [Full Text] [Related]